Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions

被引:57
作者
Balakumar, Pitchai [1 ]
Kaur, Tajpreet [2 ]
Singh, Manjeet [1 ]
机构
[1] ISF Inst Pharmaceut Sci & Drug Res, Cardiovasc Pharmacol Div, Moga 142001, Punjab, India
[2] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala, Punjab, India
关键词
vascular endothelial dysfunction; novel target sites; cardiovascular disorders;
D O I
10.1016/j.tox.2007.12.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endothelium is innermost lining of the blood vessel and it regulates the vascular tone. It plays a critical role in the mechanics of blood flow, regulation of coagulation, leukocyte adhesion, vascular smooth muscle cell (VSMC) growth and immune function. Endothelial dysfunction results in reduced vasodilatation, proinflammatory state and prothrombotic properties. Various experimental evidences revealed that reduced nitric oxide production and increased oxidative stress lead to vascular endothelial dysfunction (VED). Environmental factors such as cigarette smoking, alcohol consumption and exposure to arsenic play a critical role in the development of endothelial dysfunction. Vascular endothelial dysfunction is a hallmark for various cardiovascular disorders such as hypertension, atherosclerosis, heart failure, myocardial infarction and stroke. However, the pathological mechanism involved in the vascular endothelial dysfunction is poorly understood. The present review delineates various potential target sites for vascular endothelial dysfunction, which may open a new vista for exploring novel pharmacological agents to treat various cardiovascular disorders. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 64
页数:16
相关论文
共 227 条
  • [1] Activation of RhoA by thrombin in endothelial hyperpermeability - Role of Rho kinase and protein tyrosine kinases
    Amerongen, GPV
    van Delft, S
    Vermeer, MA
    Collard, JG
    van Hinsbergh, VWM
    [J]. CIRCULATION RESEARCH, 2000, 87 (04) : 335 - 340
  • [2] JAK-STAT pathway in cardiac ischemic stress
    Ananthakrishnan, R
    Hallam, K
    Li, Q
    Ramasamy, R
    [J]. VASCULAR PHARMACOLOGY, 2005, 43 (05) : 353 - 356
  • [3] RETRACTED: Mutual regulation of protein-tyrosine phosphatase 20 and protein-tyrosine kinase Tec activities by tyrosine phosphorylation and dephosphorylation (Retracted Article. See vol 285, pg 32678, 2010)
    Aoki, N
    Ueno, S
    Mano, H
    Yamasaki, S
    Shiota, M
    Miyazaki, H
    Yamaguchi-Aoki, Y
    Matsuda, T
    Ullrich, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) : 10765 - 10775
  • [4] Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine
    Babaei-Jadidi, R
    Karachalias, N
    Ahmed, N
    Battah, S
    Thornalley, PJ
    [J]. DIABETES, 2003, 52 (08) : 2110 - 2120
  • [5] Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway
    Bae, SW
    Kim, HS
    Cha, YN
    Park, YS
    Jo, SA
    Jo, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (04) : 981 - 987
  • [6] Balakumar P., 2006, INT J PHARM, V2, P543
  • [7] BALAKUMAR P, 2006, CLIN PHARM, V28, P683
  • [8] BALAKUMAR P, 2007, INT J BIOL CHEM, V1, P104
  • [9] Balakumar P., 2007, J PHARM TOXICOL, V2, P437
  • [10] PPAR ligands: Are they potential agents for cardiovascular disorders?
    Balakumar, Pitchai
    Rose, Madhankumar
    Singh, Manjeet
    [J]. PHARMACOLOGY, 2007, 80 (01) : 1 - 10